These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25315215)

  • 1. Predicting cardiovascular mortality in chronic kidney disease (CKD) patients.
    Sun W; Liu D; Gong P; Shi X; Wang Y; Wang P; Gong W
    Ann Transplant; 2014 Oct; 19():513-8. PubMed ID: 25315215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory syndrome in chronic kidney disease: pathogenesis and influence on outcomes.
    Filiopoulos V; Vlassopoulos D
    Inflamm Allergy Drug Targets; 2009 Dec; 8(5):369-82. PubMed ID: 20025585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal biomarkers for the prediction of cardiovascular disease.
    Joshi S; Viljoen A
    Curr Opin Cardiol; 2015 Jul; 30(4):454-60. PubMed ID: 26049396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biomarkers in Chronic Kidney Disease].
    Munguía-Miranda C; Paniagua-Sierra JR
    Rev Med Inst Mex Seguro Soc; 2017; 55(Suppl 2):S143-50. PubMed ID: 29697235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of extrapolative factors linked with oxidative injury and anti-inflammatory status in chronic kidney disease patients experiencing cardiovascular distress.
    Rasool M; Ashraf MA; Malik A; Waquar S; Khan SA; Qazi MH; Ahmad W; Asif M; Khan SU; Zaheer A; Qaisrani MM; Khan AR; Iqbal A; Raza A; Iram S; Kamran K; Iqbal A; Mustafa MZ; Choudhry H; Zamzami MA; Abdulaal WH; Jamal MS
    PLoS One; 2017; 12(2):e0171561. PubMed ID: 28178330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium in chronic kidney disease: unanswered questions.
    Spiegel DM
    Blood Purif; 2011; 31(1-3):172-6. PubMed ID: 21228586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF-23: the rise of a novel cardiovascular risk marker in CKD.
    Heine GH; Seiler S; Fliser D
    Nephrol Dial Transplant; 2012 Aug; 27(8):3072-81. PubMed ID: 22851630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium and Progression of Chronic Kidney Disease: Benefits Beyond Cardiovascular Protection?
    Sakaguchi Y; Hamano T; Isaka Y
    Adv Chronic Kidney Dis; 2018 May; 25(3):274-280. PubMed ID: 29793667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.
    Kanbay M; Yilmaz MI; Apetrii M; Saglam M; Yaman H; Unal HU; Gok M; Caglar K; Oguz Y; Yenicesu M; Cetinkaya H; Eyileten T; Acikel C; Vural A; Covic A
    Am J Nephrol; 2012; 36(3):228-37. PubMed ID: 22948239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
    Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF23: a mature renal and cardiovascular risk factor?
    Zoccali C; Yilmaz MI; Mallamaci F
    Blood Purif; 2013; 36(1):52-7. PubMed ID: 23735695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative energy balance, CKD, and risk of cardiovascular and all-cause mortality.
    Iff S; Wong G; Webster AC; Flood V; Wang JJ; Mitchell P; Craig JC
    Am J Kidney Dis; 2014 Mar; 63(3):437-45. PubMed ID: 24210588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials.
    Muñoz-Castañeda JR; Pendón-Ruiz de Mier MV; Rodríguez M; Rodríguez-Ortiz ME
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk estimated in renal transplant recipients with the Framingham score.
    de Pádua Netto MV; Bonfim TC; Costa EN; de Lima HV; Netto LC
    Transplant Proc; 2012 Oct; 44(8):2337-40. PubMed ID: 23026587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk prediction in chronic kidney disease: pitfalls and caveats.
    Rigatto C; Sood MM; Tangri N
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):612-8. PubMed ID: 23042027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy for the altered mineral metabolism of chronic kidney disease: implications for vascular calcification.
    Saab G; Whaley-Connell AT; Khanna R; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Dec; 1(2):107-12. PubMed ID: 19124399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in native and transplant kidneys: opportunities to improve prediction of outcomes in chronic kidney disease.
    De Serres SA; Varghese JC; Levin A
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):619-27. PubMed ID: 22914685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk and mineral bone disorder in patients with chronic kidney disease.
    Staude H; Jeske S; Schmitz K; Warncke G; Fischer DC
    Kidney Blood Press Res; 2013; 37(1):68-83. PubMed ID: 23548827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients.
    Provenzano M; Andreucci M; De Nicola L; Garofalo C; Battaglia Y; Borrelli S; Gagliardi I; Faga T; Michael A; Mastroroberto P; Serraino GF; Licastro N; Ielapi N; Serra R
    Biomed Res Int; 2020; 2020():2314128. PubMed ID: 33102575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.